Alexis Lilly protects public entities, institutional investors and individuals through complex litigation targeting corporate negligence and misconduct.
Alexis is a part of the firm’s team that represents dozens of governmental entities, including states, counties, cities, towns, and townships in litigation targeting the alleged deceptive marketing and over-distribution of highly addictive opioid drugs, a contended cause of the nationwide opioid crisis.
A former Motley Rice law clerk, Alexis was the Technical Editor of the American University Business Law Review, Vol. 9, and served as a student attorney for American University Washington College of Law’s Civil Advocacy Clinic in Washington, D.C., while completing her legal studies. She also assisted faculty as a Dean’s fellow for the school’s Legal Rhetoric Department, served as a judicial intern for U.S. District Judge Rudolph Contreras of the U.S. District Court for D.C., and gained valuable experience as a law clerk for the U.S. Attorney’s Office, District of Arizona.
Blog Posts
September 29, 2022
Children say Instagram worsens their mental health Causes, Not Just Cases
by: Previn Warren
July 26, 2022
Nearly $4.25 billion Teva settlement a sign opioid litigation strategy is working to abate the crisis, help communities recover Causes, Not Just Cases
by: Joseph F. Rice
February 25, 2022
Significant opioid relief finally on the way Causes, Not Just Cases
by: Joseph F. Rice
News
February 17, 2026
National Roundup Class Settlement Agreement Reached in Missouri State Court
by: Motley Rice
April 28, 2025
The history and legacy of Workers’ Memorial Day
by:
M. Nolan Webb
